Evidence map›Paper›PMID 37341605›Full record

ArticleMicrobiology spectrum2023

Clinical and Molecular Characteristics and Antibacterial Strategies of Klebsiella pneumoniae in Pyogenic Infection.

Zhiyu Yang, Runmei Zhou, Yusheng Chen, Xiaotuan Zhang, Luogen Liu, Min Luo, Jinlin Chen, Kuilin Chen, Tong Zeng, Bin Liu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Clinical, microbiological, and prognostic differences between hypermucoviscous and non-hypermucoviscous community-acquired Klebsiella pneumoniae infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. Prevalence, Risk Factors, and Clinical Outcomes of HypervirulentIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  5. A Comprehensive Overview ofInfection and drug resistance · 2025
    Review
  6. Epidemiological and characteristic differences of hypervirulent and classicalFrontiers in cellular and infection microbiology · 2025
    Article
  7. Hypervirulent Capsular Serotypes K1 and K2International journal of molecular sciences · 2024
    Article
  8. Comprehensive Analysis of Virulence Genes, Antibiotic Resistance, Biofilm Formation, and Sequence Types in Clinical Isolates ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Zhiyu Yang *Department of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Runmei Zhou *Department of Pharmacy, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Yusheng ChenDepartment of Pharmacy, Ningyuan County Hospital of Traditional Chinese Medicine, Ningyuan, Hunan, China.
Xiaotuan ZhangDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.ORCID 0000-0002-2697-3885
Luogen LiuClinical Research Center, Second Affiliated Hospital, University of South China, Hengyang, China.ORCID 0000-0003-2272-6059
Min LuoDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Jinlin ChenDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Kuilin ChenDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Tong ZengKey Laboratory of Medical Imaging and Artificial Intelligence of Hunan Province, Xiangnan University, Chenzhou, China.
Bin LiuDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Yuan WuDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Jielite HuangClinical Laboratory, Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Zhuoran LiuDepartment of Clinical Laboratory, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.ORCID 0009-0004-4762-7107
Jinglin OuyangClinical Research Center, Second Affiliated Hospital, University of South China, Hengyang, China.
University of South China · CNXiangnan University · CNXiyuan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of Klebsiella pneumoniae causing pyogenic infections is challenging. The clinical and molecular characteristics of

Indexed as

Klebsiella InfectionsVirulence FactorsAnti-Bacterial AgentsBiomarkersC-Reactive ProteinHumansKlebsiella pneumoniaeProcalcitoninAnti-Bacterial AgentsBiomarkersC-Reactive ProteinProcalcitoninVirulence Factorsantibacterial strategiesclassical Klebsiella pneumoniaeclinical and molecular characteristicsHypervirulent Klebsiella pneumoniaepyogenic infection

Identifiers

PMID37341605
PMCPMC10434161
OpenAlexW4381470479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.